Indications and uses
INDICATIONS AND USAGE: After base make-up, apply powder to the puff and apply gently. Application order : Chick - Forehead - Nose - Chin
INDICATIONS AND USAGE: After base make-up, apply powder to the puff and apply gently. Application order : Chick - Forehead - Nose - Chin
DOSAGE AND ADMINISTRATION: Take an adequate amount of this product.
Active Ingredients: Titanium Dioxide 11.64%, Ethylhexyl Methoxycinnamate 6.00%, Zinc Oxide 2.94%
INACTIVE INGREDIENT:
Mica (CI 77019), Talc, Alumina, Silica, Hexyl Laurate, HDI/Trimethylol Hexyllactone Crosspolymer, Dimethicone, Iron Oxides (CI 77492), Diphenyl Dimethicone/Vinyl Diphenyl Dimethicone/Silsesquioxane Crosspolymer, Vinyl Dimethicone/Methicone Silsesquioxane Crosspolymer, Methicone, Magnesium Myristate, Hydrogenated Lecithin, Iron Oxides (CI 77491), Methylparaben, Iron Oxides (CI 77499), Propylparaben, Fragrance(Parfum), Ultramarines (CI 77007), Water, Butylene Glycol, Calcium Carbonate, Hydrolyzed Antler Velvet, Caprylic/Capric Triglyceride, Triethoxycaprylylsilane, Phenoxyethanol, Poria Cocos Extract, Rehmannia Glutinosa Root Extract, Citrus Unshiu Peel Extract, Lithospermum Erythrorhizon Root Extract, Coptis Japonica Root Extract, Glycerin, Trichosanthes Kirilowii Root Extract, Camellia Sinensis Leaf Extract, Zizyphus Jujuba Fruit Extract, Phellodendron Amurense Bark Extract, Rosa Davurica Bud Extract, Ethylhexylglycerin, Ligularia Fishceria Leaf Extract, Glycyrrhiza Glabra (Licorice) Root Extract, Oenothera Biennis (Evening Primrose) Seed Extract, Angelica Gigas Root Extract, Prunus Mume Flower Extract, Atractyloides Japonica Rhizome Extract, Cinnamomum Cassia Bark Extract, Panax Ginseng Root Extract, Paeonia Lactiflora Root Extract, Cnidium Officinale Root Extract, Nelumbo Nucifera Flower Extract, Disodium EDTA, Prunus Mume Fruit Extract, Lactic Acid, Citric Acid
PURPOSE: SUNSCREEN
Warnings:
1. In case of having following symptoms after using this, you're advised to stop using it immediately. If you keep using it, the symptoms will get worse and need to consult a dermatologist.
1) In case of having problems such as red rash, swollenness, itching, stimulation during usage.
2) In case of having the same symptoms above on the part you put this product on by direct sunlight.
2. You are banned to use it on the part where you have a scar, eczema, or dermatitis.
3. In case of getting it into your eyes, you have to wash it immediately.
Keep out of reach of children:
Keep out of reach of babies and children
INDICATIONS AND USAGE: After base make-up, apply powder to the puff and apply gently. Application order : Chick - Forehead - Nose - Chin
DOSAGE AND ADMINISTRATION: Take an adequate amount of this product.
| Class | Version | Type | Effective |
|---|---|---|---|
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f47a510b-6679-4664-b2d6-47b5c4afe7cc | Product name | 4 | 20260217 |
| 030ce964-9b2d-45aa-b5d3-f78ce03ef61c | Product name | 2 | 20250515 |
| 0306390c-dd77-4363-afe0-63c58088b2a1 | Product name | 1 | 20220120 |
| 503ea967-4b9c-48cf-9e87-c7975295849d | Product name | 2 | 20220120 |
| 190f2a5b-bbc8-65c7-fcb0-97891307b917 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 59078-017-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b086-f424-e053-dadaa90a57ce | 8be3d0f5-1ce6-48c4-8599-1be07012196c |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59078-017-01 | The Oriental Gyeol Goun Two Way Pact | 20 g in 1 CARTON | POWDER | 20 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| Titanium Dioxide | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 1 | |
| Mica | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| Talc | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59078-017 | 59078-017-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Titanium Dioxide | 15FIX9V2JP | ACTIB |
| OCTINOXATE | 4Y5P7MUD51 | ACTIB |
| Zinc Oxide | SOI2LOH54Z | ACTIM |
| Mica | V8A1AW0880 | IACT |
| Talc | 7SEV7J4R1U | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Talc | TALC | 7SEV7J4R1U | LOZENGE / ORAL | 50 mg | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE / ORAL | 729 mg | ||
| Talc | TALC | 7SEV7J4R1U | SUSPENSION / ORAL | 234 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, FOR SUSPENSION / ORAL | 24 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE / ORAL | 349 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, SUGAR COATED / ORAL | NA | ||
| Talc | TALC | 7SEV7J4R1U | DROPS / ORAL | NA | ||
| Talc | TALC | 7SEV7J4R1U | TABLET / RECTAL | 32.4 mg | ||
| Talc | TALC | 7SEV7J4R1U | ELIXIR / ORAL | 4.5 mg/5ml | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 60 mg | ||
| Talc | TALC | 7SEV7J4R1U | POWDER, FOR SUSPENSION / ORAL | 735 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 56 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, CHEWABLE / ORAL | 202 mg | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, COATED / ORAL | 320.75 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET / BUCCAL | 15 mg | ||
| Talc | TALC | 7SEV7J4R1U | GRANULE, FOR SUSPENSION / ORAL | 296 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 18 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 357 mg | ||
| Talc | TALC | 7SEV7J4R1U | GRANULE / ORAL | 322 mg | ||
| Talc | TALC | 7SEV7J4R1U | GRANULE, DELAYED RELEASE / ORAL | 525 mg | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, EXTENDED RELEASE / ORAL | 5119 mg | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 20 mg | ||
| Talc | TALC | 7SEV7J4R1U | SUSPENSION, EXTENDED RELEASE / ORAL | 46 mg | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, DELAYED RELEASE / ORAL | 420 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, COATED / ORAL | 87 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET / SUBLINGUAL | 32.4 mg | ||
| Talc | TALC | 7SEV7J4R1U | POWDER / TOPICAL | 9235 mg | ||
| Talc | TALC | 7SEV7J4R1U | GUM, CHEWING / BUCCAL | NA | ||
| Talc | TALC | 7SEV7J4R1U | OINTMENT / TOPICAL | 74.6 %w/w | ||
| Talc | TALC | 7SEV7J4R1U | PELLET / ORAL | 69 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING / ORAL | 80 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 01c811fa-fc51-4841-b7a6-555a32be5a2e | 8be3d0f5-1ce6-48c4-8599-1be07012196c | 2013-08-03 | Warnings | 01c811fa-fc51-4841-b7a6-555a32be5a2e 8be3d0f5-1ce6-48c4-8599-1be07012196c |
Adverse event summaries are temporarily unavailable. Other product information remains available.